Com puter modeling was used to find an effective substituent for position 5 in antagonists of the luteinizing hormone-releasing hormone (LHRH). In particular, it was desired to replace ds-3-(4-pyrazinylcarbonylaminocyclohexyl)alanine in position 5 because this sub stituent is laborious to synthesize. Calculations revealed that N5-pyrazinylcarbonylornithine (PzOrn) should be a suitable substitute for cPzACAla, with N6-pyrazinylcarbonyllysine (PzLys) being a second choice. Twelve analogs were synthesized in four series with DNal or DQal in position 1 and ILys or Arg in position 8. Biological assays validated the calculations and show that antagonists with PzOrn are more potent in antiovulatory assay than antag onists with PzLys. The antagonists with PzOrn were comparable in AOA with antagonists with cPzACAla. What is also im portant, antagonists with PzOrn released significantly less histamine than those with cPzACAla.
Introduction
The luteinizing horm one-releasing hormone, LH R H ( p G lu -H is -T r p -S e r -T y r -G ly -L e u -A rg -P ro -G ly N H 2) has an essential biochemical function in mammalian reproduction. Three to four thousand LH R H antagonists have been inter nationally synthesized in the last two decades to ward finding non-steroidal and safe contraception agents [1 -8 ] .
Two effective antagonists designed in this labo ratory are Lystide [9] (N A c D Q a l-D C p a -D P a lSer -cPzA CAla-DPicLys -Leu -ILys -ProDAlaNH2) and Argtide [10] (N A c D Q a l-D C p aDPal -Ser -cPz AC Ala -DPicLys -Leu -Arg -P ro -D A laN H 2). In both antagonists position 5 is occupied by an unnatural amino acid, cis-3-(4-pyrazinylcarbonylaminocyclohexyl)alanine (cPzACAla) (1) , which was developed in our lab oratory and successful used in the num ber of LH R H antagonists [9] [10] [11] . 1 can be synthesized by platinum [12] or rhodium [13] catalyzed hydro genation of Boc-/?-aminophenylalanine, followed * Reprint requests to Prof. Dr. K. Folkers.
by separation of the ds-isom er and condensation with 4-nitrophenyl 2-pyrazinecarboxylate.
Although a significant improvement in yield was made by using a rhodium catalyst, the synthesis of 1 is still tedious and expensive. Therefore, we decided to study whether substitution of the cyclohexane ring in 1 by a carbon chain of approxi mately the same length would give an active antag onist. We used com puter modeling to study the "effective length" of the ring and how long a car bon chain should be to "mimic" it.
We report our successful effort to replace 1 with a more readily accessible and less expensive substitute.
Experimental

Materials
All a-amino functions of the amino acids were protected by the Boc group. The unnatural amino acids: Boc-DNal, Boc-DCpa, Boc-DPal and BocILys(Z) were synthesized at the Southwest Foun dation for Biomedical Research (under contract N01 HD-1-3137 with NIH), and were made avail able by the Contraceptive Development Branch, Center for Population Research, NICHD. Boc-0932-0776/95/0100-0147 $06.00 © 1995 Verlag der Zeitschrift für Naturforschung. All rights reserved. cPzACAla, Boc-PzLys, and Boc-PzOrn were pre pared in our laboratory [13, 14] .
Molecular mechanics
Com putational results were obtained using software programs from Biosym Technologies (San Diego, CA): energy minimization calcu lations from Discover® and interactive graphical display and manipulation using Insight II®. Molec ular energies were calculated using the CFF91 force field [15] .
Synthesis
The analogs were synthesized by solid phase m ethod either manually or on a Beckman 990 Peptide Synthesizer by the described protocols [10] . Purification was achieved by gel filtration on Sephadex G-25 with 6 % aq. acetic acid as the eluant, followed by column chromatography on Sephadex LH-20 with the solvent system, water: « -b u tan o l: acetic acid : methanol 90:10:10:8.
Characterization
The purified peptides showed single spots on TLC EM 0.25 mm silica gel plates in four solvent systems. The purity was further checked by ana lytical HPLC using a Waters instrum ent with 660 solvent program m er and a Vydac C 18 peptide col umn, 25x3.6 mm i.d. All peptides were 97-99% pure. Am ino acid analyses were carried out on a Beckman 118 CL Am ino Acid Analyzer after hy drolysis in constant boiling HC1 for 24 h. The un natural amino acids were qualitatively determined with the exception of Pal which was quantified. The results were in agreem ent with theory within the limits of experimental error. Calculated values for protonated molecular ions were in agreement with those obtained using FAB mass spectrometry on a 5995 Hewlett-Packard instrument. Analytical data are in Table I . 
Bioassay
Antiovulation assays were perform ed by count ing, on estrus, the num ber of ova shed by 4-day cycling rats after a single sc injection of the LH R H analog in corn oil which was administered between 12 and 12:30 p.m. on proestrus [16] . The in vitro histamine release in rat mast cells was perform ed as described [17, 18] and the results were reported as E D 50 values which is the concentration of the L H R H analog in //g/ml that releases 50% of the total releasable histamine.
Results and Discussion
Com puter modeling was used to find an effec tive substitute for cPzACAla 1 in highly active an tagonists of LHRH. For this purpose 3-(4-aminocyclohexyl)alanine was constructed and, to make the model molecule representative, both terminal amino groups were capped to create N-acetyl-3-(4-methylaminocyclohexyl)alanine 2. 
n-3 n«4
Assuming the chair conform ation of the cyclohexane ring it seemed reasonable to put the amine group in an axial position and the alkyl chain, which connects the ring to the bulky peptide back bone, in an equatorial position. The distance be tween carbon atom C2 of the peptide backbone and the side chain nitrogen atom N4 in cis-2 is a function of the two side chain dihedral angles X\ and X2-The model molecule was param eterized with the CFF91 force field and the minimized en ergy was sampled over the g~, g+ and t rotameric states of the side chain. The nine resulting conformers span an energy range of 3.13 kcal/mol (Table II) . Those three conformers with x i in the g~ state have C2 -N 4 distances in the range 5.1 to 5.3 A. All other conformers have C2 -N 4 distances in the range 5.9 to 6.1 A. In our opinion, a dis tinction between these conformers cannot be drawn unambiguously, so the distance is either 5.2 ± 0.1 A or 6.0 ± 0.1 Ä.
In order to get an idea of the correspondence between the C2 -N 4 distance in cis-2 and the equivalent distance in the linear substitute, N2-acetyl-Nx-methyl derivatives of 2,4-diaminobutyric acid (3a), ornithine (3b), lysine (3c), and homolysine (3d) were constructed (X = 4, 5, 6 , or 7 respectively) and the C2 -N x distances of the all trans chain minimum energy conformers were cal culated (Table III) . From these results it is clear that 3b has the C2 -N 5 distance (5.07 A) which "mimics" the C2 -N 4 distance in cis-2. Therefore N5-pyrazinylcarbonylornithine (PzOrn) should be the most suitable substitute for cPzACAla. The second closest distance (6.4 A) is for 3 c, which would represent N6-pyrazinylcarbonyllysine (PzLys).
To prove these theoretical results correct both, PzOrn and PzLys were synthesized and incorpo rated into LH R H analogs of the general sequence: (Table IV) . Biological tests perform ed on com pounds 4 -1 5 showed that, in all cases, analogs with PzOrn had better antiovulatory activity (AOA) than analogs with PzLys what is in agree ment with the outcome of our calculations. What is more im portant, analogs with PzOrn maintained almost the same level of AOA as analogs with cPzACAla, being even better in one case (15 vs. 13). M oreover analogs with PzOrn had always higher E D 50 values for histamine release when compared with analogs containing cPzACAla. The highest E D 50 value of 300 //g/ml was recorded for peptide 6 . In the Arg series, the best E D 50 value was 1 0 0 //g/ml for analog 12 what is an extremely good result for a peptide-containing Arg in posi tion 8 a AOA, antiovulatory activity; b H RA , histamine-releasing activity; c data from ref. [9] ; d data from ref. [10] . Abbreviations: ILys, N6-isopropyllysine; Cpa, 3-(4-chlorophenyl)alanine; Pal, 3-(3-pyridyl)alanine; PzLys, N6-pyrazinylcarbonyllysine;
PzOrn, N5-pyrazinylcarbonylornithine; Nal, 3-(2-naphthyl)alanine; Qal, 3-(3-quinolyl)alanine; PicLys, N6-picolinoyllysine.
